PortViewPortView
Xenetic Biosciences logo

Xenetic Biosciences (XBIOW) Stock Analysis

NASDAQHealthcareBiotechnology

$17.54-23.54%
1-year price historyRange $1.12 – $17.54
52-week range$17.54
$1.02$20.50

What Xenetic Biosciences does

Xenetic Biosciences, Inc. is a biopharmaceutical enterprise primarily engaged in advancing XCART, a bespoke chimeric antigen receptor T cell (CAR T) platform technology. This innovative system is engineered to specifically target unique tumor neoantigens found in individual patients. The company's broader efforts encompass the creation of various biologic therapeutics and drugs. A significant aspect of their cell-based therapeutic development is focused on addressing B-cell lymphomas by targeting the B-cell receptor present on the surface of malignant tumor cells unique to each patient. Additionally, Xenetic leverages its proprietary PolyXen drug delivery platform through strategic partnerships with other biotechnology and pharmaceutical firms. Noteworthy collaborations include agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. maintains its corporate headquarters in Framingham, Massachusetts.

Key metrics

Market cap
$5.62M
P/E (TTM)
0.00
EPS (TTM)
$0.00
Beta
2.30
Dividend yield
0.00%
Revenue / share
$1.42
50-day avg
$12.44
200-day avg
$9.05
52-week high
$20.50
52-week low
$1.02
CEO
James F. Parslow

ETFs linked to XBIOW

Broad-market and Healthcare sector ETFs an investor holding Xenetic Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how XBIOW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze XBIOW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Xenetic Biosciences?
Xenetic Biosciences trades under the ticker XBIOW on NASDAQ.
Which exchange is XBIOW listed on?
XBIOW is listed on NASDAQ.
What sector does Xenetic Biosciences operate in?
Xenetic Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze XBIOW in a portfolio?
PortView shows XBIOW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.